Effects of Quadriceps muscle activation with Neuromuscular Electrical Stimulation in patients with Congestive heart failure
Not Applicable
Recruiting
- Conditions
- Congestive Heart Failure.Systolic (congestive) heart failure
- Registration Number
- IRCT20191117045462N22
- Lead Sponsor
- Riphah International University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 54
Inclusion Criteria
45-60 years of age
Congestive Heart Failure patients
Forced expiratory volume in 1 second (FEV1) less than 50% predicted
Incapacitating breathlessness (Medical Research Council dyspnoea scale =4)
Diagnosed CHF patients
Exclusion Criteria
Neuromuscular or neurological disorders
Severe arthrosis or other musculoskeletal limitations
Implanted cardiac pacemaker
Knee osteoarthritis, Rheumatoid arthritis
Any inflammation in knee•Peripheral Neuropathy
Diagnosis of cancer
Acute exacerbation requiring hospital admission or systemic corticosteroids in the preceding 4 weeks .
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Maximal Voluntary Contraction (MVC). Timepoint: Pre- Post Treatment. Method of measurement: Dynamometer.;Left Ventricular Ejection Fraction (LVEF). Timepoint: Pre- Post Treatment. Method of measurement: Echocardiography.;The intensity of exercise. Timepoint: Pre- Post Treatment. Method of measurement: The Rate of Perceived Exertion (RPE).;Functional Capacity. Timepoint: Pre- Post Treatment. Method of measurement: 6-min Walk Test (6MWT).
- Secondary Outcome Measures
Name Time Method